These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Felbamate: restrictions on use. Farrington E Pediatr Nurs; 1995; 21(2):188, 200. PubMed ID: 7746687 [No Abstract] [Full Text] [Related]
5. The rise and fall of felbamate as a treatment for partial epilepsy--aplastic anemia and hepatic failure to blame? Thakkar K; Billa G; Rane J; Chudasama H; Goswami S; Shah R Expert Rev Neurother; 2015; 15(12):1373-5. PubMed ID: 26566191 [TBL] [Abstract][Full Text] [Related]
10. Is there any future for felbamate treatment? Borowicz KK; Piskorska B; Kimber-Trojnar Z; Małek R; Sobieszek G; Czuczwar SJ Pol J Pharmacol; 2004; 56(3):289-94. PubMed ID: 15215558 [TBL] [Abstract][Full Text] [Related]
11. Evaluating the safety and efficacy of felbamate in the context of a black box warning: A single center experience. Shah YD; Singh K; Friedman D; Devinsky O; Kothare SV Epilepsy Behav; 2016 Mar; 56():50-3. PubMed ID: 26828692 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of case reports of aplastic anemia among patients treated with felbamate. Kaufman DW; Kelly JP; Anderson T; Harmon DC; Shapiro S Epilepsia; 1997 Dec; 38(12):1265-9. PubMed ID: 9578520 [TBL] [Abstract][Full Text] [Related]
13. Felbamate in therapy-resistant epilepsy: an Italian experience. Felbamate Italian Study Group. Avanzini G; Canger R; Dalla Bernardina B; Vigevano F Epilepsy Res; 1996 Nov; 25(3):249-55. PubMed ID: 8956923 [TBL] [Abstract][Full Text] [Related]
14. Felbamate: clinical and molecular aspects of a unique antiepileptic drug. Brown WM; Aiken SP Crit Rev Neurobiol; 1998; 12(3):205-22. PubMed ID: 9847055 [TBL] [Abstract][Full Text] [Related]